Sort
21,453 grants matching “tuberculosis”
TUBERCULOSIS ELIMINATION AND LABORATORY
$332,102Richard Brostrom · Cnmi Department Of Public Health · U52 · FY2006 · PS
Group 1 CD1 in Infectious Disease and T Cell Development
$332,000University Of Chicago · R01 · FY2005 · AI
Toxic Metal Complexation By de Novo Designed Peptides
$331,965Vincent L. Pecoraro · University Of Michigan At Ann Arbor · R01 · FY2017 · ES
Design/Syntheses/Studies/Novel Antituberculosis Agents
$331,951University Of Notre Dame · R01 · FY2005 · AI
UCSD Collaborative Clinical Trials Unit
$331,939Timothy J Wilkin · University Of California, San Diego · UM1 · FY2025 · AI
Bacterial Cell Wall Composition and the Influence of Antibiotics
$331,888Lynette S Cegelski · Stanford University · R01 · FY2022 · GM
Bacterial Cell Wall Composition and the Influence of Antibiotics
$331,888Lynette S Cegelski · Stanford University · R01 · FY2023 · GM
Role of MmpL transporters in M. tuberculosis virulence
$331,875University Of California San Francisco · R01 · FY2001 · AI
Role of MmpL transporters in M. tuberculosis virulence
$331,875University Of California San Francisco · R01 · FY2005 · AI
Role of MmpL transporters in M. tuberculosis virulence
$331,875University Of California San Francisco · R01 · FY2004 · AI
Role of MmpL transporters in M. tuberculosis virulence
$331,875University Of California San Francisco · R01 · FY2003 · AI
Metabolic carbohydrate cell wall probes for bacterial structure and immune recognition studies
$331,784Catherine Leimkuhler Grimes · University Of Delaware · U01 · FY2019 · CA
T regulatory cells and immunity in tuberculosis
$331,776Kevin B Urdahl · Seattle Biomedical Research Institute · R01 · FY2010 · AI
Development of TB Cell Wall Inhibitors
$331,714Richard Edward Lee · Colorado State University · P01 · FY2006 · AI
Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in
$331,693Sydney Rosen · Boston University Medical Campus · U01 · FY2012 · AI
Biology of alveolar macrophages in aging and tuberculosis
$331,385Larry S. Schlesinger · Texas Biomedical Research Institute · P01 · FY2020 · AG
Refined Capture-Recapture Methods for Surveilling Cancer Recurrence
$331,379Robert H Lyles · Emory University · R01 · FY2024 · CA
Molecular Determinants of M. tuberculosis virulence
$331,349Issar Smith · Public Health Research Institute · R01 · FY2006 · AI
Virulence of the Opportunistic Pathogen Rhodococcis Equi
$331,200Mary Hondalus · University Of Georgia · R01 · FY2006 · AI
Biosynthesis of unusual bio-orthogonal functionalities in natural products
$331,160Wenjun Zhang · University Of California Berkeley · R01 · FY2020 · GM
Neuropathogenesis and Neuroinvasiveness of Subtype C Human Immunodeficiency Virus
$331,117Charles Wood · University Of Nebraska Lincoln · R01 · FY2013 · NS
Flavin-Containing Monooxygenase in Lung
$331,109David E. Williams · Oregon State University · R01 · FY2013 · HL
Seeking efficiency and innovation in syntheses of bioactive compounds
$331,079Erik J. Sorensen · Princeton University · R01 · FY2012 · GM
Multiplex TB-M.avium complex Fluorescent in Situ hybridization Assay, direct from
$331,069Jyotsna S Shah · Id Fish Technology, Inc. · R43 · FY2009 · AI
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIV
$331,057James C M Brust · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · AI